The Biotech world converges on San Diego next week for the BIO International Convention. Highlights of the week include the Arizona Pavilion (#5519) featuring AquaLung Therapeutics, Avery Therapeutics, Axolotl Biologix, Pharos Dx, and TGenEducational and Company presentations at BIO 2017 will feature AZBio Members from Amgen, Beacon Biomedical, BMS, C-Path, Genentech, GSK, HealthCatalysts, HealthTell, Icagen, Lilly, Merck, NuvOx, Roche, Sanofi, and Susavion
AZBio will be kicking off BIO week with a full day at RESI where over 400 qualified investors will be sharing insights and connecting with life science companies in Health IT, Medical Devices, Diagnostics, and BioPharmacueticals.
AZBio Member News
ASU students team up with Barrow to create medical rehab devices ASU students create 3 solutions to help those with impaired mobility. Entrepreneurship-based class teaches how to move devices out of lab, into world.
UA College of Medicine Phoenix Receives Full Accreditation After successfully navigating the accreditation process that began six years ago, the UA College of Medicine – Phoenix has been granted full accreditation by the Liaison Committee on Medical Education (LCME).
SenesTech Launches Second Manufacturing Line in Flagstaff to Ensure Uninterrupted Supply SenesTech, Inc. (NASDAQ: SNES), has launched its second manufacturing line in Flagstaff. With the addition of this second line, the Company’s existing manufacturing capacity is expected to more than double.
C-PATH and CDISC Announce Public Review Period for Duchenne Therapeutic Area Standard The Clinical Data Interchange Standards Consortium (CDISC) and Critical Path Institute (C-Path) announce the availability of a Duchenne muscular dystrophy therapeutic area user guide (TAUG-DMD v1.0) for public review.
ASU engineer working to develop disposable point-of-care sensor The project aims to develop a disposable, point-of-care biosensor for rapid diagnosis and health monitoring, supported by a four-year, $1.8 million Smart and Connected Health award from the National Science Foundation.
VisionGate Hires Prominent Pathologist as Medical Director Former Massachusetts General Hospital’s Dr. David Wilbur To Oversee VisionGate’s CLIA laboratory. VisionGate’s ground-breaking technology can help eradicate not only the world’s deadliest disease – lung cancer — but other cancers as well.